Phase 0 trials articles from across Nature Portfolio

Phase 0 trials are conducted to obtain preliminary data on the pharmacokinetic and pharmacodynamic properties of an investigational therapeutic. They involve the administration of single subtherapeutic doses (often called microdoses) of the therapeutic to a small number of subjects (typically 10 to 15).

Latest Research and Reviews

News and Comment